4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-022620
PRESIDENT AND CEO sold 30,320 shares at an average $36.84 ($1,117,140)
- PRESIDENT AND CEO acquired 15,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-28 | Option exercise 10b5-1 | +14,925 | $2.90 | $43,235 | 337,592 | D: show line 1 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-28 | Sale 10b5-1 | −14,925 | $36.80 | $549,241 | 322,667 | D: show line 2 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-28 | Option exercise 10b5-1 | +700 | $2.90 | $2,028 | 323,367 | D: show line 3 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-28 | Sale 10b5-1 | −700 | $37.54 | $26,275 | 322,667 | D: show line 4 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-28 | Sale 10b5-1 | −13,995 | $36.82 | $515,353 | 308,672 | D: show line 5 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-28 | Sale 10b5-1 | −700 | $37.53 | $26,270 | 307,972 | D: show line 6 in the form |
| Open-market sales · 30,320 sh · avg $36.84 · $1,117,140 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-28 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 842,962 | D: show line 7 in the form |
Loading xslF345X05/form4-08302024_080840.xml…